Premium
The Bombay High Court has dismissed a case against Intas Pharmaceuticals Ltd filed by a rival drugmaker alleging violation of intellectual property rights, in a judgment that could have broader implications.The court has quashed a petition filed by Mumbai-based Ajanta Pharma Ltd and said that mere similarities between the names ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
